Giulia Cerretti

701 total citations
30 papers, 402 citations indexed

About

Giulia Cerretti is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Giulia Cerretti has authored 30 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in Giulia Cerretti's work include Glioma Diagnosis and Treatment (29 papers), Brain Metastases and Treatment (9 papers) and Cancer Genomics and Diagnostics (7 papers). Giulia Cerretti is often cited by papers focused on Glioma Diagnosis and Treatment (29 papers), Brain Metastases and Treatment (9 papers) and Cancer Genomics and Diagnostics (7 papers). Giulia Cerretti collaborates with scholars based in Italy, France and Switzerland. Giulia Cerretti's co-authors include Giuseppe Lombardi, Mario Caccese, Vittorina Zagonel, Marta Padovan, Ahmed Idbaïh, Pim J. French, Cristina Birzu, Alessia Pellerino, Émeline Tabouret and Renzo Manara and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

Giulia Cerretti

25 papers receiving 397 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giulia Cerretti Italy 10 281 107 78 77 73 30 402
Marta Padovan Italy 13 282 1.0× 91 0.9× 79 1.0× 76 1.0× 80 1.1× 47 435
Theophilos Tzaridis Germany 13 235 0.8× 156 1.5× 70 0.9× 97 1.3× 118 1.6× 27 401
Jethro Hu United States 13 295 1.0× 139 1.3× 85 1.1× 112 1.5× 52 0.7× 34 471
Jennifer M. Eschbacher United States 12 155 0.6× 110 1.0× 57 0.7× 52 0.7× 78 1.1× 18 432
Julien Dimastromatteo United States 11 162 0.6× 169 1.6× 63 0.8× 54 0.7× 69 0.9× 21 496
Toni Rose Jue Australia 9 153 0.5× 103 1.0× 53 0.7× 62 0.8× 39 0.5× 16 311
Zhiyong Qin China 9 146 0.5× 88 0.8× 46 0.6× 101 1.3× 40 0.5× 19 290
Mart A. A. M. Heesters Netherlands 8 235 0.8× 104 1.0× 98 1.3× 69 0.9× 186 2.5× 10 472
Sigmund Hsu United States 9 318 1.1× 160 1.5× 160 2.1× 88 1.1× 57 0.8× 26 498
Jianyi Ding United States 5 254 0.9× 258 2.4× 71 0.9× 185 2.4× 60 0.8× 6 501

Countries citing papers authored by Giulia Cerretti

Since Specialization
Citations

This map shows the geographic impact of Giulia Cerretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulia Cerretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulia Cerretti more than expected).

Fields of papers citing papers by Giulia Cerretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulia Cerretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulia Cerretti. The network helps show where Giulia Cerretti may publish in the future.

Co-authorship network of co-authors of Giulia Cerretti

This figure shows the co-authorship network connecting the top 25 collaborators of Giulia Cerretti. A scholar is included among the top collaborators of Giulia Cerretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulia Cerretti. Giulia Cerretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cerretti, Giulia, Alberto Bosio, Mario Caccese, et al.. (2025). Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience. Journal of Neuro-Oncology. 173(2). 449–456. 1 indexed citations
2.
Padovan, Marta, Matteo Simonelli, Amedeo De Nicolò, et al.. (2025). A phase 1, first-in-human study of regorafenib plus temozolomide with or without radiotherapy in patients with newly diagnosed MGMT methylated, IDHwt glioblastoma: The REGOMA-2 trial.. Journal of Clinical Oncology. 43(16_suppl). 2068–2068.
3.
Cerretti, Giulia, et al.. (2024). Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a GOPC::ROS1 fusion. Neuro-Oncology Advances. 6(1). vdae077–vdae077.
4.
Cerretti, Giulia, Angela Guerriero, Francesco Volpin, et al.. (2024). Relationship between glioblastoma location and O6-methylguanine-DNA methyltransferase promoter methylation percentage. Brain Communications. 6(6). fcae415–fcae415. 2 indexed citations
5.
Ius, Tamara, Nicola Montemurro, Giuseppe Lombardi, et al.. (2024). Decoding the puzzle: A multidisciplinary systematic review of adult brainstem glioma. Critical Reviews in Oncology/Hematology. 196. 104261–104261. 1 indexed citations
6.
Persico, Pasquale, Mario Caccese, Marta Padovan, et al.. (2024). PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives. Cancer Treatment Reviews. 131. 102850–102850. 2 indexed citations
7.
Cerretti, Giulia, Marta Padovan, Cândida Toni, et al.. (2023). 502MO Target therapy matched to genomic alterations in patients with recurrent IDH wildtype glioblastoma: A real-life cohort analysis from Veneto Institute of Oncology, Padua (Italy). Annals of Oncology. 34. S393–S393. 2 indexed citations
8.
Caccese, Mario, Susanna Mandruzzato, Alba Fiorentino, et al.. (2023). Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities. The Oncologist. 29(4). 289–302. 10 indexed citations
9.
Caccese, Mario, F. Busato, Angela Guerriero, et al.. (2023). The role of radiation therapy and systemic treatments in meningioma: The present and the future. Cancer Medicine. 12(15). 16041–16053. 5 indexed citations
10.
Bosio, Albino Claudio, Giulia Cerretti, Marta Padovan, et al.. (2023). Metronomic Temozolomide in Heavily Pretreated Patients With Recurrent Isocitrate Dehydrogenase Wild-type Glioblastoma: A Large Real-Life Mono-Institutional Study. Clinical Oncology. 35(5). e319–e327. 3 indexed citations
11.
12.
Caccese, Mario, Isacco Desideri, Marta Padovan, et al.. (2023). Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study. Journal of Neuro-Oncology. 163(2). 377–383. 2 indexed citations
13.
Cerretti, Giulia, Federico Pessina, Enrico Franceschi, et al.. (2023). Spinal ependymoma in adults: from molecular advances to new treatment perspectives. Frontiers in Oncology. 13. 1301179–1301179. 5 indexed citations
14.
Pace, Andrea, Giuseppe Lombardi, Veronica Villani, et al.. (2023). Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated MGMT gene promoter: RACTAC, a phase II multicenter trial. Frontiers in Oncology. 13. 1320710–1320710. 6 indexed citations
15.
Padovan, Marta, Giulia Cerretti, Mario Caccese, et al.. (2023). Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series. Expert Review of Endocrinology & Metabolism. 18(2). 181–198. 3 indexed citations
16.
Giunco, Silvia, Marta Padovan, C. Angelini, et al.. (2023). Prognostic role and interaction of TERT promoter status, telomere length and MGMT promoter methylation in newly diagnosed IDH wild-type glioblastoma patients. ESMO Open. 8(3). 101570–101570. 15 indexed citations
17.
18.
Caccese, Mario, Giulia Cerretti, Marta Padovan, Vittorina Zagonel, & Giuseppe Lombardi. (2021). 359P Regorafenib in recurrent glioblastoma patients: A large real-life experience. Annals of Oncology. 32. S522–S522.
19.
Bellu, Luisa, Mario Caccese, Giulia Cerretti, et al.. (2021). Gliomatosis cerebri: a monocentric real-life experience. Journal of Cancer Metastasis and Treatment. 2 indexed citations
20.
Lombardi, Giuseppe, Valeria Barresi, Antonella Castellano, et al.. (2020). Clinical Management of Diffuse Low-Grade Gliomas. Cancers. 12(10). 3008–3008. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Padovan Breakdown of academic impact, for papers by Theophilos Tzaridis Breakdown of academic impact, for papers by Jethro Hu Breakdown of academic impact, for papers by Jennifer M. Eschbacher Breakdown of academic impact, for papers by Julien Dimastromatteo Breakdown of academic impact, for papers by Toni Rose Jue Breakdown of academic impact, for papers by Zhiyong Qin Breakdown of academic impact, for papers by Mart A. A. M. Heesters Breakdown of academic impact, for papers by Sigmund Hsu Breakdown of academic impact, for papers by Jianyi Ding
Rankless by CCL
2026